82 related articles for article (PubMed ID: 8392982)
21. L-myc genotypes in Hong Kong Chinese colorectal carcinoma patients.
Ko JM; Cheung MH; Wong C; Lau K; Tang CM; Kwan MW; Lung ML
Oncol Rep; 1999; 6(2):441-4. PubMed ID: 10023018
[TBL] [Abstract][Full Text] [Related]
22. Genetic variation in the microRNA-499 gene and hepatocellular carcinoma risk in a Turkish population: lack of any association in a case-control study.
Akkiz H; Bayram S; Bekar A; Akgöllü E; Üsküdar O
Asian Pac J Cancer Prev; 2011; 12(11):3107-12. PubMed ID: 22393998
[TBL] [Abstract][Full Text] [Related]
23. Homozygosity for Pro of p53 Arg72Pro as a potential risk factor for hepatocellular carcinoma in Chinese population.
Zhu ZZ; Cong WM; Liu SF; Dong H; Zhu GS; Wu MC
World J Gastroenterol; 2005 Jan; 11(2):289-92. PubMed ID: 15633234
[TBL] [Abstract][Full Text] [Related]
24. Study on the DNA repair gene XRCC1 and XRCC3 polymorphism in prediction and prognosis of hepatocellular carcinoma risk.
Han X; Xing Q; Li Y; Sun J; Ji H; Huazheng P; Jun L
Hepatogastroenterology; 2012 Oct; 59(119):2285-9. PubMed ID: 22456434
[TBL] [Abstract][Full Text] [Related]
25. Serum PAI-1 and PAI-1 4G/5G Polymorphism in Hepatitis C Virus-Induced Cirrhosis and Hepatitis C Virus-Induced Hepatocellular Carcinoma Patients.
El Edel RH; Essa ES; Essa AS; Hegazy SA; El Rowedy DI
Viral Immunol; 2016 Nov; 29(9):510-515. PubMed ID: 27459171
[TBL] [Abstract][Full Text] [Related]
26. Lack of an association of programmed cell death-1 PD1.3 polymorphism with risk of hepatocellular carcinoma susceptibility in Turkish population: a case-control study.
Bayram S; Akkız H; Ülger Y; Bekar A; Akgöllü E; Yıldırım S
Gene; 2012 Dec; 511(2):308-13. PubMed ID: 23041554
[TBL] [Abstract][Full Text] [Related]
27. [Clinical significance of c-myc oncogene amplification in primary hepatocellular carcinoma by interphase fluorescence in situ hybridization].
Fang Y; Huang B; Liang Q; Li H; Huang C
Zhonghua Bing Li Xue Za Zhi; 2001 Jun; 30(3):180-2. PubMed ID: 11866973
[TBL] [Abstract][Full Text] [Related]
28. The MTHFR C677T mutation is not a risk factor recognized for HBV-related HCC in a population with a high prevalence of this genetic marker.
Jiao X; Luo Y; Yang B; Jing L; Li Y; Liu C; Jing X; Wang F; Wang Y; Du Z; Gao Y
Infect Genet Evol; 2017 Apr; 49():66-72. PubMed ID: 28082187
[TBL] [Abstract][Full Text] [Related]
29. Association of PNPLA3 Polymorphism with Hepatocellular Carcinoma Development and Prognosis in Viral and Non-Viral Chronic Liver Diseases.
Khlaiphuengsin A; Kiatbumrung R; Payungporn S; Pinjaroen N; Tangkijvanich P
Asian Pac J Cancer Prev; 2015; 16(18):8377-82. PubMed ID: 26745088
[TBL] [Abstract][Full Text] [Related]
30. L-MYC and GSTM1 polymorphisms are associated with unfavourable clinical parameters of gliomas.
Kondratieva TV; Imyanitov EN; Togo AV; Zaitseva OA; Yatsuk OS; Romanenko SM; Bersnev VP; Hanson KP
J Exp Clin Cancer Res; 2000 Jun; 19(2):197-200. PubMed ID: 10965818
[TBL] [Abstract][Full Text] [Related]
31. No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case-control study.
Akkız H; Bayram S; Bekar A; Akgöllü E; Usküdar O; Sandıkçı M
Gene; 2011 Oct; 486(1-2):104-9. PubMed ID: 21807077
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of trail receptor 1 (DR4) polymorphisms C626G and A683C as risk factors of hepatocellular carcinoma.
Alsalawy NF; Darwish RK; Kamal MM; ElTaweel AE; Shousha HI; Elbaz TM
J Med Virol; 2018 Mar; 90(3):490-496. PubMed ID: 28975649
[TBL] [Abstract][Full Text] [Related]
33. [p53 gene codon 72 polymorphism and genetic susceptibility to hepatocellular carcinoma in Chinese population].
Zhu ZZ; Cong WM; Liu SF; Dong H; Zhu GS; Wu MC
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(2):76-9. PubMed ID: 15774209
[TBL] [Abstract][Full Text] [Related]
34. CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer.
Silvestri L; Sonzogni L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Leveri M; Cividini A; Mondelli MU; Civardi E; Silini EM
Int J Cancer; 2003 Apr; 104(3):310-7. PubMed ID: 12569554
[TBL] [Abstract][Full Text] [Related]
35. Increased frequency of the S allele of the L-myc oncogene in non-Hodgkin's lymphoma.
Crossen PE; Morrison MJ; Colls BM
Br J Cancer; 1994 Apr; 69(4):759-61. PubMed ID: 7908219
[TBL] [Abstract][Full Text] [Related]
36. Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients.
Motawi TK; Shaker OG; Ismail MF; Sayed NH
Gene; 2013 Sep; 527(2):516-20. PubMed ID: 23845776
[TBL] [Abstract][Full Text] [Related]
37. No association of the exonuclease 1 T439M polymorphism and risk of hepatocellular carcinoma development in the Turkish population: a case-control study.
Bayram S; Akkiz H; Bekar A; Akgöllü E; Yıldırım S
Asian Pac J Cancer Prev; 2011; 12(9):2455-60. PubMed ID: 22296401
[TBL] [Abstract][Full Text] [Related]
38. Association between interleukin-21 gene polymorphisms (rs12508721) and HBV-related hepatocellular carcinoma.
Zhang QX; Li SL; Yao YQ; Li TJ
Int J Immunogenet; 2016 Jun; 43(3):151-8. PubMed ID: 27122304
[TBL] [Abstract][Full Text] [Related]
39. The 14bp-deletion allele in the HLA-G gene confers susceptibility to the development of hepatocellular carcinoma in the Brazilian population.
Teixeira AC; Mendes-Junior CT; Souza FF; Marano LA; Deghaide NH; Ferreira SC; Mente ED; Sankarankutty AK; Elias-Junior J; Castro-e-Silva O; Donadi EA; Martinelli AL
Tissue Antigens; 2013 Jun; 81(6):408-13. PubMed ID: 23506091
[TBL] [Abstract][Full Text] [Related]
40. Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma.
Yu MW; Gladek-Yarborough A; Chiamprasert S; Santella RM; Liaw YF; Chen CJ
Gastroenterology; 1995 Oct; 109(4):1266-73. PubMed ID: 7557094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]